References

Tamoxifen: catalyst for the change to targeted therapy

10.1016/j.ejca.2007.11.002 · 2008 · External reference

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors

10.1200/jco.2004.05.192 · 2004 · External reference

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis

10.1093/annonc/mdv590 · 2016 · External reference

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy

10.1002/cpt.1007 · 2018 · External reference

Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study

10.1093/jnci/djr079 · 2011 · External reference

Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer

10.1200/jco.2012.44.5015 · 2013 · External reference

Use of low-dose tamoxifen to increase mammographic screening sensitivity in premenopausal women

10.3390/cancers13020302 · 2021 · External reference

Unresolved reference

2025 · External reference

A clinical model for identifying the short-term risk of breast cancer

10.1186/s13058-017-0820-y · 2017 · External reference

Identification of women at high risk of breast cancer who need supplemental screening

10.1148/radiol.2020201620 · 2020 · External reference

A comprehensive tool for measuring mammographic density changes over time

10.1007/s10549-018-4690-5 · 2018 · External reference

Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp)

10.1186/s12913-025-12471-9 · 2025 · External reference

The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer

10.1093/jnci/dji069 · 2005 · External reference

Low-dose tamoxifen for mammographic density reduction: a randomized controlled trial

10.1200/jco.20.02598 · 2021 · External reference

The comparison of several dose levels with a zero dose control

10.2307/2556164 · 1972 · External reference

Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial

10.1093/jnci/djae280 · 2025 · External reference

Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia

10.1200/jco.18.01779 · 2019 · External reference

Side effects of adjuvant treatment of breast cancer

10.1056/nejm200106283442607 · 2001 · External reference

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

10.1038/s41416-023-02293-z · 2023 · External reference

Efficacy and safety of endoxifen in bipolar disorder: a systematic review

10.1002/hup.2899 · 2024 · External reference

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer

10.1093/jnci/dju425 · 2015 · External reference

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

10.1016/s0140-6736(11)60993-8 · 2011 · External reference